NCT01733004View on ClinicalTrials.gov

A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2016

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

MM-141

Trial Locations (4)

Unknown

Marietta

Boston

Detroit

Villejuif

Sponsors
All Listed Sponsors
lead

Merrimack Pharmaceuticals

INDUSTRY

NCT01733004 - A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter